Bioassay-guided isolation of DPP-4 inhibitory fractions from extracts of submerged cultured of Inonotus obliquus

Molecules

Volumn 18, Issue 1, 2013, Pages 1150-1161

  Geng, Yan ^a   Lu, Zhen Ming ^a   Huang, Wei ^a   Xu, Hong Yu ^a   Shi, Jin Song ^a   Xu, Zheng Hong ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

Bioassay guided isolation; DPP 4 inhibitor; Inonotus obliquus; UPLC Q TOF MS Molecular docking

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV; DIPEPTIDYL PEPTIDASE IV INHIBITOR; HETEROCYCLIC COMPOUND;

AGARICALES; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CULTURE TECHNIQUE; ENZYME ASSAY; FERMENTATION; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR DOCKING; MOLECULAR WEIGHT; MYCELIUM; PROTEIN BINDING;

AGARICALES; CULTURE TECHNIQUES; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; ENZYME ASSAYS; FERMENTATION; HETEROCYCLIC COMPOUNDS; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR DOCKING SIMULATION; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; MYCELIUM; PROTEIN BINDING;

MLCS; MLOWN;

EID: 84872871661     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18011150     Document Type: Article

References (35)

1. Taylor, S.I. Deconstructing type 2 diabetes. Cell 1999, 97, 9-12.
2. Chen, L.; Magliano, D.J.; Zimmet, P.Z. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat. Rev. Endocrinol. 2012, 8, 228-236.
3. Cornell, S. Key considerations in pharmacotherapy for type 2 diabetes mellitus: A multiple target organ approach. J. Clin. Pharm. Ther. 2012, 37, 254-259.
4. Barnett, A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int. J. Clin. Pract. 2006, 60, 1454-1470.
5. Drucker, D.J. Glucagon-like peptides. Diabetes 1998, 47, 159-169.
6. Rosenstock, J.; Zinman, B. Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 2007, 14, 98-107.
7. Utzschneider, K.M.; Tong, J.; Montgomery, B.; Udayasankar, J.; Gerchman, F.; Marcovina, S.M.; Watson, C.E.; Ligueros-Saylan, M.A.; Foley, J.E.; Holst, J.J.; et al. The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose. Diabetes Care 2008, 31, 108-113.
8. Williams-Herman, D.; Round, E.; Swern, A.; Musser, B.; Davies, M.J.; Kaufman, K.D.; Amatruda, J.M. Safety and tolerability of sitagliptin, a selective DPP-4 inhibitor, in patients with type 2 diabetes: Pooled analysis of 6139 patients in clinical trials for tip to 2 years. Diabetologia 2008, 51, S365-S366.
9. Ahren, B.; Simonsson, E.; Larsson, H.; Landin-Olsson, M.; Torgeirsson, H.; Jansson, P.A.; Sandqvist, M.; Bavenholm, P.; Efendic, S.; Eriksson, J.W.; et al. Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care 2002, 25, 869-875.
10. Covington, P.; Christopher, R.; Davenport, M.; Fleck, P.; Mekki, Q.A.; Wann, E.R.; Karim, A. Pharmacokinetic, Pharmacodynamic, And tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, Double-blind, Placebo-controlled, Multiple-dose study in adult patients with type 2 diabetes. Clin. Ther. 2008, 30, 499-512.
11. Huang, N.L. Inonotus obliquus. Edible Fungi of China 2002, 21, 7-8.
12. Sun, J.E.; Ao, Z.H.; Lu, Z.M.; Xu, H.Y.; Zhang, X.M.; Dou, W.F.; Xu, Z.H. Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J. Ethnopharmacol. 2008, 118, 7-13.
13. Shibnev, V.A.; Mishin, D.V.; Garaev, T.M.; Finogenova, N.P.; Botikov, A.G.; Deryabin, P.G. Antiviral activity of Inonotus obliquus fungus extract towards infection caused by hepatitis C virus in cell cultures. Bull. Exp. Biol. Med. 2011, 151, 612-614.
14. Cui, Y.; Kim, D.S.; Park, K.C. Antioxidant effect of Inonotus obliquus. J. Ethnopharmacol. 2005, 96, 79-85.
15. Kim, Y.O.; Park, H.W.; Kim, J.H.; Lee, J.Y.; Moon, S.H.; Shin, C.S. Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci. 2006, 79, 72-80.
16. Taji, S.; Yamada, T.; Wada, S.; Tokuda, H.; Sakuma, K.; Tanaka, R. Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity. Eur. J. Med. Chem. 2008, 43, 2373-2379.
17. Kim, Y.J.; Park, J.; Min, B.S.; Shim, S.H. Chemical Constituents from the Sclerotia of Inonotus obliquus. J. Korean Soc. Appl Bi. 2011, 54, 287-294.
18. Zjawiony, J.K. Biologically active compounds from aphyllophorales (polypore) fungi. J. Nat. Prod. 2004, 67, 300-310.
19. Fazenda, M.L.; Seviour, R.; McNeil, B.; Harvey, L.M. Submerged culture fermentation of "higher fungi": The macrofungi. Adv. Appl. Microbiol. 2008, 63, 33-103.
20. Mohamed, H.N.; Man, Y.C.; Mustafa, S.; Manap, Y.A. Tentative identification of volatile flavor compounds in commercial Budu, A Malaysian fish sauce, Using GC-MS. Molecules 2012, 17, 5062-5080.
21. Bukvicki, D.; Gottardi, D.; Veljic, M.; Marin, P.D.; Vannini, L.; Guerzoni, M.E. Identification of volatile components of liverwort (Porella cordaeana) extracts using GC/MS-SPME and their antimicrobial activity. Molecules 2012, 17, 6982-6995.
22. Liu, J.; Tang, X.; Zhang, Y.; Zhao, W. Determination of the volatile composition in brown millet, milled millet and millet bran by gas chromatography/mass spectrometry. Molecules 2012, 17, 2271-2282.
23. Careri, M.; Mangia, A.; Musci, M. Overview of the applications of liquid chromatography-mass spectrometry interfacing systems in food analysis: Naturally occurring substances in food. J. Chromatogr. A 1998, 794, 263-297.
24. Xing, J.; Xie, C.; Lou, H. Recent applications of liquid chromatography-mass spectrometry in natural products bioanalysis. J. Pharm. Biomed. Anal. 2007, 44, 368-378.
25. Rodríguez-Medina, I.C.; Segura-Carretero, A.; Fernández- Gutiérrez, A. Use of high-performance liquid chromatography with diode array detection coupled to electrospray-Qq-time-of-flight mass spectrometry for the direct characterization of the phenolic fraction in organic commercial juices. J. Chromatogr. A 2009, 1216, 4736-4744.
26. Wei, S.D.; Zhou, H.C.; Lin, Y.M. Antioxidant Activities of Extract and Fractions from the Hypocotyls of the Mangrove Plant Kandelia candel. Int. J. Mol. Sci. 2010, 11, 4080-4093.
27. Wei, S.D.; Zhou, H.C.; Lin, Y.M. Antioxidant Activities of Fractions of Polymeric Procyanidins from Stem Bark of Acacia confusa. Int. J. Mol. Sci. 2011, 12, 1146-1160.
28. Shin, Y.; Tamai, Y.; Terazawa, M. Chemical constituents of Inonotus obliquus II: A new triterpene, 21,24-cyclopentalanosta-3 beta,21,25-triol-8-ene from sclerotium. J. Wood Sci. 2001, 47, 313-316.
29. Nakajima, Y.; Sato, Y.; Konishi, T. Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga). Chem. Pharm. Bull. 2007, 55, 1222-1226.
30. Zhukovich, E.N.; Semenova, M.Y.; Sharikova, L.A.; Pribytkova, T.F. Tetracyclic triterpenes from Inonotus obliquus (PERS.) PIL. (CHAGA) growing in Russia. Pharm. Chem. J. 2010, 44, 495-496.
31. Sun, Y.; Yin, T.; Chen, X.H.; Zhang, G.; Curtis, R.B.; Lu, Z.H.; Jiang, J.H. In Vitro Antitumor Activity and Structure Characterization of Ethanol Extracts from Wild and Cultivated Chaga Medicinal Mushroom, Inonotus obliquus (Pers.:Fr.) Pilat (Aphyllophoromycetideae). Int. J. Med. Mushrooms 2011, 13, 121-130.
32. Kim, H.J.; Jin, C.; Lee, S.L. Antioxidative activities of phenolic compounds isolated from Inonotus obliquus. Kor. J. Pharmacogn. 2007, 38, 164-169.
33. Morris, G.M.; Lim-Wilby, M. Molecular docking. Methods Mol. Biol. 2008, 443, 365-382.
34. Xu, H.Y.; Sun, J.E.; Lu, Z.M.; Zhang, X.M.; Dou, W.F.; Xu, Z.H. Beneficial effects of the ethanol extract from the dry matter of a culture broth of Inonotus obliquus in submerged culture on the antioxidant defence system and regeneration of pancreatic-cells in experimental diabetes in mice. Nat. Prod. Res. 2010, 24, 542-553.
35. Xu, X.; Pang, C.; Yang, C.J.; Zheng, Y.T.; Xu, H.Y.; Lu, Z.M.; Xu, Z.H. Antihyperglycemic and Antilipidperoxidative Effects of Polysaccharides Extracted from Medicinal Mushroom Chaga, Inonotus obliquus (Pers.: Fr.) Pilat (Aphyllophoromycetideae) on Alloxan-Diabetes Mice. Int. J. Med. Mushrooms 2010, 12, 235-244.